St. Jude’s Epic Year Wins Over Investors; MDDI Index Up 15% In 2004

St. Jude Medical's entry into the cardiac resynchronization therapy ICD market and expanded atrial fibrillation business helped capture the attention of Wall Street and potential suitors in 2004 as its stock jumped 37% for the year